The integration of single-cell sequencing, TCGA, and GEO data analysis revealed that PRRT3-AS1 is a biomarker and therapeutic target of SKCM
2022 · Frontiers in Immunology · 37 citations
https://doi.org/10.3389/fimmu.2022.919145
X
Xuqi Xie
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Xuqi Xie is an academic researcher.
Papers by this author
worksChat about Author
Papers
Chat
Click to start Chat